Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 661 across all filing types
Latest filing 2026-03-24 Notice of Dividend Amou…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
关于未来三年（2026年-2028年）股东分红回报规划
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement regarding the company's dividend distribution policy and planning for the next three years (2026-2028). It outlines principles, conditions, decision-making procedures, and implementation mechanisms for shareholder dividends. It does not contain financial statements or results but focuses on the policy and planning aspect of dividends. The document is relatively short (2648 characters) and is a formal policy announcement rather than a report or financial statement. Therefore, it fits best under the category of Notice of Dividend Amount (DIV), as it relates to dividend planning and shareholder returns.
2026-03-24 Chinese
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding Shenzhen Huitai Medical Device Co., Ltd.'s use of temporarily idle raised funds for cash management. It references regulatory approvals, fundraising details, investment amounts, risk analysis, and compliance with relevant securities regulations. The document is not a full financial report but a specialized audit or verification report related to the use of raised funds. It does not contain comprehensive financial statements or quarterly/yearly financial results. The document length is 3616 characters, which is relatively short but contains substantive content about the audit and verification of cash management of raised funds. This fits the definition of an Audit Report / Information (AR) rather than a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Q1 2026
2026-03-24 Chinese
2025年度独立董事述职报告(夏立军-已离任)
Board/Management Information Classification · 95% confidence The document is a detailed report by an independent director of Shenzhen Huitai Medical Devices Co., Ltd. for the year 2025. It covers the director's background, attendance at board and committee meetings, oversight activities, opinions on financial reports, audit firm appointments, and other governance matters. The content focuses on the independent director's duties, evaluations, and opinions on company governance and financial oversight during the year. This type of document is a formal report by an independent director on their annual duties and performance, which is distinct from general annual reports or audit reports. It is not a financial statement or earnings release, nor is it an announcement or proxy solicitation. The document fits the category of Board/Management Information (MANG), as it relates to board-level governance and management oversight information provided by an independent director.
2026-03-24 Chinese
关于召开2025年年度股东会的通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2025 Annual General Meeting (AGM) of Shenzhen Huitai Medical Devices Co., Ltd. It includes details such as the meeting date, voting methods, agenda items to be discussed and voted on, and instructions for shareholders on how to attend and vote. The document does not contain the actual annual report or financial statements but rather the notification and procedural information for the AGM. The document length is 4395 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2026-03-24 Chinese
关于2026年度“提质增效重回报”行动方案暨2025年度评估报告
Annual Report Classification · 95% confidence The document is a detailed report from Shenzhen Huitai Medical Devices Co., Ltd. regarding their 2026 annual action plan and the evaluation report for 2025. It covers comprehensive operational, financial, governance, R&D, market, and investor relations information. The content includes financial performance data, strategic plans, governance reforms, and detailed business updates for the fiscal year 2025 and plans for 2026. The length is over 7,000 characters and contains substantive financial and operational data, not just an announcement or summary. It is not a transcript, proxy statement, or a simple announcement. This matches the characteristics of an Annual Report (10-K) which provides a full yearly report covering company activity and financial performance. FY 2025
2026-03-24 Chinese
2025年度独立董事述职报告（朱援祥-已离任）
Board/Management Information Classification · 95% confidence The document is a detailed report by an independent director of Shenzhen Huitai Medical Devices Co., Ltd. for the year 2025. It covers the director's background, attendance at meetings, participation in committees, review of financial reports, audit firm appointment, related party transactions, board nominations, remuneration, and overall evaluation of the company's governance and operations during the year. The content focuses on the independent director's duties and oversight rather than financial results or audit opinions alone. This type of document is typically classified as a Management Report or a Director's Report on their duties and governance activities. It is not an Annual Report (10-K), Audit Report (AR), or a simple announcement. Given the nature and detailed content about board and management activities, the best fitting category is Board/Management Information (MANG).
2026-03-24 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.